LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)
Clinical trial NCT03354754 · TERMINATED
Trial details
- NCT number
- NCT03354754
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2018-09-24
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.